| Online-Ressource |
Verfasst von: | Kröger, Knut [VerfasserIn]  |
| Schwertfeger, M. [VerfasserIn]  |
| Pittrow, D. [VerfasserIn]  |
| Diehm, Curt [VerfasserIn]  |
Titel: | Management of patients with peripheral arterial disease in primary care |
Titelzusatz: | a cross-sectional study in Germany |
Verf.angabe: | K. Kröger, M. Schwertfeger, D. Pittrow, C. Diehm |
E-Jahr: | 2010 |
Jahr: | 17 May 2010 |
Umfang: | 10 S. |
Fussnoten: | Gesehen am 06.03.2023 |
Titel Quelle: | Enthalten in: The international journal of clinical practice |
Ort Quelle: | London : Hindawi Limited, 2004 |
Jahr Quelle: | 2010 |
Band/Heft Quelle: | 64(2010), 7, Seite 875-884 |
ISSN Quelle: | 1742-1241 |
Abstract: | Background: Studies in the primary care setting are of high interest for assessing the management situation of patients with manifestations of atherothrombosis. Aims: Therefore, we documented diagnostic procedures, characteristics, and management of patients with symptomatic and asymptomatic peripheral arterial disease (PAD). Materials & Methods: Prospective cross-sectional study in primary care practices throughout Germany. Results: A total of 671 patients with newly diagnosed PAD were included (mean age 69.1 years; 62.1% men). Cardiovascular risk factors were highly prevalent in the total PAD group: arterial hypertension in 84.2%, hyperlipidaemia in 75.5%, present smoking in 45.0% and diabetes mellitus in 47.3%. Atherothrombotic comorbidities were also frequent: coronary artery disease in 44.9% and cerebrovascular disease in 28.1%. For confirmation of diagnosis, patients were referred to specialists in 66.9% of cases. Overall, ankle brachial index was measured in 89.0%, and a clinical PAD score assessed in 66.6% (agreement of both measures with Cohen’s kappa only, κ = 0.039; p = 0.209). Drug treatment of risk factors (as secondary prophylaxis) in line with current guidelines was reported in a high percentage of patients: 88.6% with any antiplatelet drug, 69.3% with statins, 62.4% with angiotensin converting enzyme inhibitors, 23.5% with AT1 receptor blockers and 43.9% with beta-blockers. Between asymptomatic and symptomatic PAD, differences in the risk factor/comorbidity profiles were small; however, the latter group received intensified treatment. Conclusion: Our findings confirm that patients with PAD pose a substantial challenge to physicians because of their high number of comorbidities. Compared with previous studies, management of such patients appears to have improved. |
DOI: | doi:10.1111/j.1742-1241.2010.02337.x |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: https://doi.org/10.1111/j.1742-1241.2010.02337.x |
| Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1742-1241.2010.02337.x |
| DOI: https://doi.org/10.1111/j.1742-1241.2010.02337.x |
Datenträger: | Online-Ressource |
Sprache: | eng |
K10plus-PPN: | 1838178147 |
Verknüpfungen: | → Zeitschrift |
Management of patients with peripheral arterial disease in primary care / Kröger, Knut [VerfasserIn]; 17 May 2010 (Online-Ressource)